BRCA2 and neoplasm: These results showed that the combination of BRCA2 and ROCK2 inhibitors was more effective than using BRCA2 inhibitor alone in inhibiting MCF7 tumor cells after 24-h treatment, suggesting a potential strategy for enhancing BRCA2 inhibitor sensitivity.